TITLE

Painkiller abuse targeted

PUB. DATE

April 2001

SOURCE

State Government News;Apr2001, Vol. 44 Issue 4, p6

SOURCE TYPE

Periodical

DOC. TYPE

Article

ABSTRACT

Reports that Purdue Pharma, manufacturer of OxyContin, has agreed to take steps to enforce the proper use of the painkiller. Number of deaths caused by the abuse of the drug; Steps that Purdue Pharma has agreed to take in order to promote proper prescription-drug use.

ACCESSION #

4987814

Tags: DRUG abuse -- Prevention;  PURDUE Pharma LP;  ANALGESICS

 

Related Articles

• NEW DRUGS.  // Drug Topics;2/7/2005, Vol. 149 Issue 3, p91 

  No abstract available.

• Long-acting oxycodone available.  // Drug Topics;6/10/96, Vol. 140 Issue 11, p10 

  Reports on the availability of OxyContin (oxocodone) extended-release tables from Purdue Pharma LP. Controlled-release formulation of the opioid analgesic.

• BUTRANS.  // Monthly Prescribing Reference;Jan2011, Vol. 27 Issue 1, pA.7 

  The article provides brief information on Butrans, an opioid analgesic from Purdue Pharma LP, which is used to treat moderate to severe chronic pain.

• FDA: Reformulated OxyContin May Be Less Prone to Abuse. Young, Donna // BioWorld Today;4/7/2010, Vol. 21 Issue 66, p1 

  The article reports on the approval granted by the U.S. Food and Drug Administration (FDA) to Purdue Pharma LP to sell a reformulated version of its potent controlled-release oxycodone drug, OxyContin, in 2010. The drug is intended to prevent abusers from cutting, breaking, or chewing the...

• BUTRANS.  // MPR - Residents' Edition;Spring/Summer2011, Vol. 20 Issue 1, pA.6 

  The article offers brief information on the opioid analgesic Butrans, which is indicated for the treatment of moderate-to-severe pain, from Purdue Pharma LP.

• Profits vs. Pain Relief. Rosenberg, Debra // Newsweek (Atlantic Edition);7/2/2001, Vol. 138 Issue 1, p39 

  Reports on a case against Purdue Pharma on charges that the painkiller OxyContin was prescribed to patients without warnings of risk of addiction. Involvement of addicts, family members of addicts and others in the case in the United States; Idea that the drug was marketed too aggressively.

• Profits vs. Pain Relief. Rosenberg, Debra // Newsweek (Pacific Edition);7/2/2001, Vol. 138 Issue 1, p21 

  Reports on a case against Purdue Pharma on charges that the painkiller OxyContin was prescribed to patients without warnings of risk of addiction. Involvement of addicts, family members of addicts and others in the case in the United States; Idea that the drug was marketed too aggressively.

• Profits vs. Pain Relief. Rosenberg, Debra // Newsweek;7/2/2001, Vol. 138 Issue 1, p49 

  Reports on a case against Purdue Pharma on charges that the painkiller OxyContin was prescribed to patients without warnings of risk of addiction. Involvement of addicts, family members of addicts and others in the case in the United States; Idea that the drug was marketed too aggressively.

• Rival drug makers battle over pain killer. Spear, Linda // Fairfield County Business Journal;06/05/2000, Vol. 39 Issue 23, p2 

  Reports on the legal dispute between pharmaceutical firms Purdue Pharma LP and Roxane Laboratories Inc. over a patented sustained-release pain control product. Court order in favor of Purdue Pharma's patent position for the drug Oxycondin; Generic reproduction of the drug by rival Roxane...

Read the Article